Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology: Neuroimmunology & Neuroinflammation COVID-19 Article Hub
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology Neuroimmunology & Neuroinflammation
Home
A peer-reviewed clinical and translational neurology open access journal
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • COVID-19 Article Hub
  • Infographics & Video Summaries

Share

July 2019; 6 (4) Clinical/Scientific NotesOpen Access

Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis

View ORCID ProfileMichiel H.F. Poorthuis, View ORCID ProfileJosephus L.M. van Rooij, Anna H. Koch, Annelies E.M. Verdonkschot, Machteld M. Leembruggen, View ORCID ProfileMaarten J. Titulaer
First published June 4, 2019, DOI: https://doi.org/10.1212/NXI.0000000000000579
Michiel H.F. Poorthuis
From the Department of Neurology (M.H.F.P., J.L.M.R., M.M.L.) and Department of Gynaecology (A.H.K., A.E.M.V.), Tergooi, Blaricum; and Department of Neurology (M.J.T.), Erasmus MC, Rotterdam, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michiel H.F. Poorthuis
Josephus L.M. van Rooij
From the Department of Neurology (M.H.F.P., J.L.M.R., M.M.L.) and Department of Gynaecology (A.H.K., A.E.M.V.), Tergooi, Blaricum; and Department of Neurology (M.J.T.), Erasmus MC, Rotterdam, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Josephus L.M. van Rooij
Anna H. Koch
From the Department of Neurology (M.H.F.P., J.L.M.R., M.M.L.) and Department of Gynaecology (A.H.K., A.E.M.V.), Tergooi, Blaricum; and Department of Neurology (M.J.T.), Erasmus MC, Rotterdam, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annelies E.M. Verdonkschot
From the Department of Neurology (M.H.F.P., J.L.M.R., M.M.L.) and Department of Gynaecology (A.H.K., A.E.M.V.), Tergooi, Blaricum; and Department of Neurology (M.J.T.), Erasmus MC, Rotterdam, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Machteld M. Leembruggen
From the Department of Neurology (M.H.F.P., J.L.M.R., M.M.L.) and Department of Gynaecology (A.H.K., A.E.M.V.), Tergooi, Blaricum; and Department of Neurology (M.J.T.), Erasmus MC, Rotterdam, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maarten J. Titulaer
From the Department of Neurology (M.H.F.P., J.L.M.R., M.M.L.) and Department of Gynaecology (A.H.K., A.E.M.V.), Tergooi, Blaricum; and Department of Neurology (M.J.T.), Erasmus MC, Rotterdam, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maarten J. Titulaer
Full PDF
Citation
Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis
Michiel H.F. Poorthuis, Josephus L.M. van Rooij, Anna H. Koch, Annelies E.M. Verdonkschot, Machteld M. Leembruggen, Maarten J. Titulaer
Neurol Neuroimmunol Neuroinflamm Jul 2019, 6 (4) e579; DOI: 10.1212/NXI.0000000000000579

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
867

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 6 no. 4 e579
DOI: 
https://doi.org/10.1212/NXI.0000000000000579
PubMed: 
31355315

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received January 3, 2019
  • Accepted in final form April 21, 2019
  • First Published June 4, 2019.

Copyright & Usage: 
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Michiel H.F. Poorthuis, MD,
    2. Josephus L.M. van Rooij, MD,
    3. Anna H. Koch, MD,
    4. Annelies E.M. Verdonkschot, MD,
    5. Machteld M. Leembruggen, MD, PhD and
    6. Maarten J. Titulaer, MD, PhD
  1. Michiel H.F. Poorthuis, MD,
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  3. Josephus L.M. van Rooij, MD,
  4. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  5. Anna H. Koch, MD,
  6. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  7. Annelies E.M. Verdonkschot, MD,
  8. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  9. Machteld M. Leembruggen, MD, PhD and
  10. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  11. Maarten J. Titulaer, MD, PhD
  12. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. (1) Neurology: Neuroimmunology & Neuroinflammation, since June 2014

    Patents:
    1. (1) filed a patent for "methods for typing neurological disorders and cancer, and devices for use therein" specifically about diagnostics for anti-GABAB receptor antibodies and KCTD antibodies.

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. (1) Medimmune LLC, research funds for serving on the scientific advisory board; (2) Guidepoint Global LLC, research funds for consultancy; (3) Novartis, research funds for teaching; (4) unrestricted research grant from Euroimmun AG.

    Research Support, Government Entities:
    1. (1) supported by the Netherlands Organisation for Scientific Research (NWO, Veni incentive and Memorabel initiative)

    Research Support, Academic Entities:
    1. (1) Previously supported by an ErasmusMC fellowship

    Research Support, Foundations and Societies:
    1. (1) supported by the Dutch Epilepsy Foundations, projectnumber 14-19.

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  1. From the Department of Neurology (M.H.F.P., J.L.M.R., M.M.L.) and Department of Gynaecology (A.H.K., A.E.M.V.), Tergooi, Blaricum; and Department of Neurology (M.J.T.), Erasmus MC, Rotterdam, The Netherlands.
  1. Correspondence
    Dr. Titulaer m.titulaer{at}erasmusmc.nl
View Full Text

Article usage

Article usage: June 2019 to May 2023

AbstractFullPdfSource
Jun 201911899107Highwire
Jul 2019438558Highwire
Aug 2019345275Highwire
Sep 2019413733Highwire
Oct 20191114516Highwire
Nov 201929127Highwire
Dec 201929211Highwire
Jan 202026511Highwire
Feb 202008613Highwire
Mar 20201606Highwire
Apr 202008812Highwire
May 202008520Highwire
Jun 202006112Highwire
Jul 202006634Highwire
Aug 202006718Highwire
Sep 202016613Highwire
Oct 202008339Highwire
Nov 20202539Highwire
Dec 20202638Highwire
Jan 202127614Highwire
Feb 202103324Highwire
Mar 20210496Highwire
Apr 202126621Highwire
May 202113910Highwire
Jun 20211385Highwire
Jul 202114112Highwire
Aug 20211478Highwire
Sep 202114212Highwire
Oct 202104925Highwire
Nov 202104618Highwire
Dec 202103824Highwire
Jan 202205110Highwire
Feb 20221425Highwire
Mar 20220405Highwire
Apr 20220409Highwire
May 20221359Highwire
Jun 20221207Highwire
Jul 20221315Highwire
Aug 20220468Highwire
Sep 202214118Highwire
Oct 20221748Highwire
Nov 202209025Highwire
Dec 20221194Highwire
Jan 20230406Highwire
Feb 20231398Highwire
Mar 202314712Highwire
Apr 202302811Highwire
May 202302716Highwire

Cited By...

  • 10 Citations
  • Google Scholar

Letters: Rapid online correspondence

  • Reader response: Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis
    • Nicolas X. Urriola, Clinical Immunologist, Neurologist and Immunopathologst, Royal Prince Alfred Hospital, Sydney, Australia
    Submitted August 09, 2019
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Case report
    • Discussion
    • Study funding
    • Disclosure
    • Acknowledgment
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke: A Post Hoc Analysis of the EXTEND-IA TNK Trials

Dr. Nicole Sur and Dr. Mausaminben Hathidara

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Autoimmune diseases
  • Encephalitis
  • Paraneoplastic syndrome

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Article
    Decreased occipital lobe metabolism by FDG-PET/CT
    An anti–NMDA receptor encephalitis biomarker
    John C. Probasco, Lilja Solnes, Abhinav Nalluri et al.
    Neurology: Neuroimmunology & Neuroinflammation, November 15, 2017
  • Articles
    Analysis of relapses in anti-NMDAR encephalitis
    I. Gabilondo, A. Saiz, L. Galán et al.
    Neurology, August 24, 2011
  • Case
    Pregnancy and delivery in anti-NMDA receptor encephalitis survivors
    Norito Kokubun, Tomoko Komagamine, Koichi Hirata et al.
    Neurology: Clinical Practice, March 08, 2016
  • Special Article
    NMDA receptor encephalitis and other antibody-mediated disorders of the synapse
    The 2016 Cotzias Lecture
    Josep Dalmau et al.
    Neurology, December 05, 2016
Neurology - Neuroimmunology Neuroinflammation: 10 (4)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Neuroimmunology & Neuroinflammation
Online ISSN: 2332-7812

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise